Clinical benefit and safety profile of cross-line therapy with CDK4/6 inhibitors: a retrospective study of HR+/HER2– advanced breast cancer

2024-9-11

Weight gain after 35 years of age is associated with increased breast cancer risk: findings from a large prospective cohort study

2024-8-27

The current role of dendritic cells in the progression and treatment of colorectal cancer

2024-8-22

Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine

2024-8-9

Global, regional, and national burden of early-onset gastric cancer

2024-8-7

Esophageal cancer global burden profiles, trends, and contributors

2024-7-26

Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study

2024-7-26

Impact of cancer diagnosis on life expectancy by area-level socioeconomic groups in New South Wales, Australia: a population-based study

2024-7-22

Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei

2024-7-18

Attributable liver cancer deaths and disability-adjusted life years in China and worldwide: profiles and changing trends

2024-7-16

Epigenetic regulators as the foundation for molecular classification of colorectal cancer

2024-7-16

Multiple myeloma survival in New South Wales, Australia, by treatment era to 2020

2024-7-11

The role of reactive oxygen species in gastric cancer

2024-7-9

ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis

2024-7-1

Modeling human gastric cancers in immunocompetent mice

2024-6-28

MicroRNA-384 radiosensitizes human non-small cell lung cancer by impairing DNA damage response and repair signaling, which is inhibited by NF-κB

2024-6-27

Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants

2024-6-26

Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research

2024-6-25

Research progress in tumor angiogenesis and drug resistance in breast cancer

2024-6-25

Amplifying colorectal cancer progression: impact of a PDIA4/SP1 positive feedback loop by circPDIA4 sponging miR-9-5p

2024-6-21

Effectiveness of colorectal cancer screening integrating non-genetic and genetic risk: a prospective study based on UK Biobank data

2024-6-20

Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells

2024-5-31

Enhancement of anti-PD-L1 antibody plus anlotinib efficacy due to downregulation of PD-L1 in the micro-conduit endothelium within the tumor: a randomized double-blind trial

2024-5-29

Immune checkpoint inhibitors: breakthroughs in cancer treatment

2024-5-24

Roles of cancer-associated fibroblast functional heterogeneity in shaping the lymphatic metastatic landscape: new insights and therapeutic strategies

2024-5-22

Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer

2024-5-16

Advances in MET tyrosine kinase inhibitors in gastric cancer

2024-5-10

Development of small molecule drugs targeting immune checkpoints

2024-5-9

Comprehensive understanding of glioblastoma molecular phenotypes: classification, characteristics, and transition

2024-5-6

Impact of metabolic dysfunction-associated steatotic liver disease on the efficacy of immunotherapy in patients with chronic hepatitis B-related hepatocellular carcinoma

2024-5-6

Calcification-associated molecular traits and therapeutic strategies in hormone receptor-positive HER2-negative breast cancer

2024-4-9

A retrospective analysis of mature T- and NK-cell lymphomas

2024-3-27

Erratum to Treatment strategies for patients with HER2-positive gastric cancer

2024-3-27

Reducing the global cancer burden with gastrointestinal screening: China’s 30 years practice

2024-3-27

Decreased LDHB expression in breast tumor cells causes NK cell activation and promotes tumor progression

2024-3-25

Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial

2024-3-4

Blockade of CD300A enhances the ability of human NK cells to lyse hematologic malignancies

2024-2-29

Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China

2024-2-28

Current and future trends in whole genome sequencing in cancer

2024-2-15

Insight into the evolution of breast cancer driven by genetic alterations

2024-2-5

Azoximer bromide and hydroxyapatite: promising immune adjuvants in cancer

2024-2-5

Nodal peripheral T-cell lymphomas in the new classification systems

2024-2-5

The Warburg effect drives dedifferentiation through epigenetic reprogramming

2024-2-5

Drug clinical trials on high-grade gliomas: challenges and hopes

2024-2-5

Hot issues in triple-negative breast cancer

2024-2-5

Road of no return — loss of TP53 paves a defined evolution path from gastric preneoplasia-to-cancer

2024-2-5

Treatment strategies for patients with HER2-positive gastric cancer

2024-2-5

Diagnosis of malnutrition in cancer patients

2024-2-5

Advances in ATM, ATR, WEE1, and CHK1/2 inhibitors in the treatment of PARP inhibitor-resistant ovarian cancer

2024-2-5

DNA methylation biomarkers for early detection of gastric and colorectal cancers

2024-2-5